Fructooligosaccharides Market Report 2026

The fructooligosaccharides market size has grown strongly in recent years. It will grow from $3.17 billion in 2025 to $3.42 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising consumer health awareness, expansion of functional foods, demand for sugar alternatives, growth in dietary supplements, infant nutrition market growth.

The fructooligosaccharides market size is expected to see strong growth in the next few years. It will grow to $4.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to preventive healthcare adoption, microbiome research expansion, clean label food demand, aging population nutrition needs, functional beverage innovation. Major trends in the forecast period include growing demand for prebiotic ingredients, increasing use in functional food formulations, rising adoption in infant nutrition products, expansion of low-calorie sweetener applications, focus on gut health and digestive wellness.

The increasing prevalence of obesity is expected to propel the growth of the fructooligosaccharides market going forward. Obesity is a long-term health condition characterized by excessive body fat accumulation that can harm overall health. Its rising prevalence is linked to the widespread availability of high-calorie, high-fat, and high-sugar foods, sedentary behaviors, and reduced levels of physical activity. Fructooligosaccharides (FOS) are used as dietary supplements or functional food ingredients to support obesity management. FOS may help improve lipid and glucose metabolism, potentially aiding energy utilization and weight control. For example, in March 2023, according to the World Heart Foundation, approximately 2.3 billion adults and children worldwide were overweight or obese, with the number projected to reach 2.7 billion by 2025. Therefore, increasing concerns about obesity are driving the fructooligosaccharides market.

Major companies operating in the fructooligosaccharides (FOS) market are focusing on developing innovative products such as short-chain fructooligosaccharides (scFOS) that support sugar reduction and deliver prebiotic benefits to improve nutritional quality, digestive health, and calorie reduction. Short-chain fructooligosaccharides (scFOS) consist of 3-4 fructose units with a terminal glucose unit and resist digestion in the small intestine, functioning as dietary fiber. Compared to traditional sweeteners such as sucrose or high-fructose corn syrup, scFOS offers mild sweetness, reduced caloric contribution, and improved support for gut microbiota. For instance, in May 2023, BENEO GmbH, a Germany-based functional ingredients company, introduced Beneo-scL85, a short-chain fructooligosaccharide syrup formulated for sugar reduction and fiber enhancement. Derived from beet sugar, it provides good solubility and mild sweetness, suitable for bakery, dairy, and cereal applications, enabling manufacturers to achieve reduced-sugar nutrition labeling while promoting gut health.

In February 2025, SEQENS, a France-based provider of specialty chemicals and enzyme-driven bioprocessing solutions, partnered with Applexion to expand its global presence in the fructooligosaccharides (FOS) market by utilizing Applexion’s distribution network to accelerate the adoption of enzyme-based scFOS production technologies. Applexion, a U.S.-based distributor specializing in supply-chain solutions for the agro-food sector, will distribute SEQENZYM FT, improving global access to high-purity prebiotic FOS ingredients.

Major companies operating in the fructooligosaccharides market are Beneo GmbH, Sensus, Cosucra Groupe Warcoing, Baolingbao Biology Co. Ltd., Quantum Hi-Tech (China) Biological Co. Ltd., Galam Ltd., Tereos Group, Südzucker AG, Beghin-Meiji SA, CJ CheilJedang, Nissin Sugar Co. Ltd., Meiji Holdings Co. Ltd., Yakult Honsha Co. Ltd., Ingredion Incorporated, Tate & Lyle PLC, Cargill Incorporated, Nippon Beet Sugar Manufacturing, Baolingbao Health Food, Shandong Bailong Chuangyuan Bio-Tech, Fujian Zhuoyue New Energy.

North America was the largest region in the fructooligosaccharides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fructooligosaccharides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fructooligosaccharides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fructooligosaccharides market consists of sales of Inulin-derived fructooligosaccharides, Levan-type fructooligosaccharides, Neosugar, and Synthesized fructooligosaccharides. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.